Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weldon

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Journal of Virology|November 20, 2015
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End GameSabine M G van der Sanden, Weilin Wu, Naomi Dybdahl-Sissoko, et al.
Pediatrics|October 9, 2019
Acute Flaccid Myelitis in the United States: 2015-2017Tracy Ayers, Adriana Lopez, Adria Lee, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery systemJessica A White, Jeremy S Blum, Nancy A Hosken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Trends in Poliovirus Seroprevalence in Kano State, Northern NigeriaHarish Verma, Zubairu Iliyasu, Kehinde T Craig, et al.
Vaccine|April 17, 2016
The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in NepalCristina V Cardemil, Concepcion Estivariz, Laxman Shrestha, et al.
The Lancet. Infectious Diseases|June 22, 2015
Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trialConcepción F Estívariz, Abhijeet Anand, Howard E Gary, et al.
Plos One|September 27, 2017
Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern NigeriaMustapha Modu Gofama, Harish Verma, Hamisu Abdullahi, et al.
The Lancet. Infectious Diseases|August 31, 2015
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority studyMiguel O'Ryan, Ananda S Bandyopadhyay, Rodolfo Villena, et al.
Journal of Virology|July 5, 2005
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutantsAlexander B H Bakker, Wilfred E Marissen, R Arjen Kramer, et al.
Vaccine|December 9, 2015
Effect of substituting IPV for tOPV on immunity to poliovirus in Bangladeshi infants: An open-label randomized controlled trialJosyf C Mychaleckyj, Rashidul Haque, Marya Carmolli, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Journal of Virology|November 20, 2015
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End GameSabine M G van der Sanden, Weilin Wu, Naomi Dybdahl-Sissoko, et al.
Pediatrics|October 9, 2019
Acute Flaccid Myelitis in the United States: 2015-2017Tracy Ayers, Adriana Lopez, Adria Lee, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery systemJessica A White, Jeremy S Blum, Nancy A Hosken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Trends in Poliovirus Seroprevalence in Kano State, Northern NigeriaHarish Verma, Zubairu Iliyasu, Kehinde T Craig, et al.
Vaccine|April 17, 2016
The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in NepalCristina V Cardemil, Concepcion Estivariz, Laxman Shrestha, et al.
The Lancet. Infectious Diseases|June 22, 2015
Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trialConcepción F Estívariz, Abhijeet Anand, Howard E Gary, et al.
Plos One|September 27, 2017
Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern NigeriaMustapha Modu Gofama, Harish Verma, Hamisu Abdullahi, et al.
The Lancet. Infectious Diseases|August 31, 2015
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority studyMiguel O'Ryan, Ananda S Bandyopadhyay, Rodolfo Villena, et al.
Journal of Virology|July 5, 2005
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutantsAlexander B H Bakker, Wilfred E Marissen, R Arjen Kramer, et al.
Vaccine|December 9, 2015
Effect of substituting IPV for tOPV on immunity to poliovirus in Bangladeshi infants: An open-label randomized controlled trialJosyf C Mychaleckyj, Rashidul Haque, Marya Carmolli, et al.
Pageof 16